Autologous vs Allografts, page-10

Umm, huh?
Fiona Wood has been involved, since inception.

The Wiki listing actually lists her as founder;
http://en.wikipedia.org/wiki/Avita_Medical

And Fiona is mentioned on Avita's web site;
http://www.avitamedical.com/?ob=1&id=25

"The technology has been developed over the last decade driven by the vision of Prof Fiona Wood, and Ms Marie Stoner."

It's not like she hasn't been involved already.

This SMH article says it all.
http://www.smh.com.au/business/spra...cal-faces-investor-revolt-20131117-2xp49.html

I "invested" in CCE based on the fact Fiona Wood was involved.
8 years on, how has that helped?
It hasn't.

Yes, I trusted her.

And I can validate the SMH claim of the share price plunging by 95%.
Each one of my AVH shares owes me $3.50.

Being AVH, this is obviously after the 1 for 10 consolidation.
(I want to make that crystal clear, before any ill informed TOU attempt.)
AVH.

If you want to refer to it as CCE, then do not confuse the pre/post consolidation share prices.

You can always check historical price charts, before and after the merge and consolidation.

And prior to merge and consolidation, each CCE share was $0.35 each, although it actually climbed much higher at the time.
I'll give forum viewers enough credit to do the basic pre/post math.

IMO, if anyone thinks FDA approval, when/if that may occur, thinks the share price is going to get back to anywhere near where it originally was, is absolutely dreaming.

And people wonder why there is so much bad blood associated with this company, and therefore a complete lack of trust, and ultimately, a lack of investment.

So from my experience, and with all due respect, having Fiona Wood involved has not helped us so far.
Keep the scientists in the white coats developing and enhancing.
Use people who can actually market, to do the marketing.

It's always been a mistake to let back-end technical staff be involved with marketing.
This is how they tended to do it early on.
It didn't work then.

Granted, the management have since, IMO, been absolutely incompetent in commercialising what should have been a revolutionary no-brainer.